EGFR Tyrosine Kinase Inhibitor–Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic

Detalles Bibliográficos
Autores principales: Chang, Hsu-Liang, Chen, Yen-Hsu, Taiwan, Hsin-Chu, Yang, Chih-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199722/
https://www.ncbi.nlm.nih.gov/pubmed/32387581
http://dx.doi.org/10.1016/j.jtho.2020.04.029
_version_ 1783529202859900928
author Chang, Hsu-Liang
Chen, Yen-Hsu
Taiwan, Hsin-Chu
Yang, Chih-Jen
author_facet Chang, Hsu-Liang
Chen, Yen-Hsu
Taiwan, Hsin-Chu
Yang, Chih-Jen
author_sort Chang, Hsu-Liang
collection PubMed
description
format Online
Article
Text
id pubmed-7199722
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer.
record_format MEDLINE/PubMed
spelling pubmed-71997222020-05-06 EGFR Tyrosine Kinase Inhibitor–Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic Chang, Hsu-Liang Chen, Yen-Hsu Taiwan, Hsin-Chu Yang, Chih-Jen J Thorac Oncol Article Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer. 2020-08 2020-05-05 /pmc/articles/PMC7199722/ /pubmed/32387581 http://dx.doi.org/10.1016/j.jtho.2020.04.029 Text en © 2020 Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Chang, Hsu-Liang
Chen, Yen-Hsu
Taiwan, Hsin-Chu
Yang, Chih-Jen
EGFR Tyrosine Kinase Inhibitor–Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
title EGFR Tyrosine Kinase Inhibitor–Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
title_full EGFR Tyrosine Kinase Inhibitor–Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
title_fullStr EGFR Tyrosine Kinase Inhibitor–Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
title_full_unstemmed EGFR Tyrosine Kinase Inhibitor–Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
title_short EGFR Tyrosine Kinase Inhibitor–Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
title_sort egfr tyrosine kinase inhibitor–associated interstitial lung disease during the coronavirus disease 2019 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199722/
https://www.ncbi.nlm.nih.gov/pubmed/32387581
http://dx.doi.org/10.1016/j.jtho.2020.04.029
work_keys_str_mv AT changhsuliang egfrtyrosinekinaseinhibitorassociatedinterstitiallungdiseaseduringthecoronavirusdisease2019pandemic
AT chenyenhsu egfrtyrosinekinaseinhibitorassociatedinterstitiallungdiseaseduringthecoronavirusdisease2019pandemic
AT taiwanhsinchu egfrtyrosinekinaseinhibitorassociatedinterstitiallungdiseaseduringthecoronavirusdisease2019pandemic
AT yangchihjen egfrtyrosinekinaseinhibitorassociatedinterstitiallungdiseaseduringthecoronavirusdisease2019pandemic

Ejemplares similares